Navigation Links
Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
Date:4/16/2012

primary mission to broaden access to care by providing safe and effective recombinant therapies and advancing innovation for people living with hemophilia. Inspiration has a broad portfolio of recombinant hemophilia product candidates, which includes one under review by the FDA and EMA for marketing approval in the U.S. and Europe, one in late-stage clinical development, and two preclinical programs.

Inspiration's lead product candidates are IB1001 and OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product being developed for the treatment of individuals with congenital hemophilia A who have developed inhibitors against human FVIII, and for individuals with acquired hemophilia.  Inspiration has earlier-stage development programs focused on human recombinant factor VIIa (rFVIIa) for individuals with either hemophilia A or hemophilia B who have developed inhibitors or those with factor VII deficiency, and human recombinant FVIII for individuals with hemophilia A.

Inspiration's senior management team has broad experience and expertise in hemophilia product development, biologics manufacturing and the successful commercialization of products to treat hemophilia and other rare diseases.

In January 2010, Inspiration entered into a strategic agreement with Ipsen (EURONEXT: IPN; ADR: IPSEY), leveraging the combined expertise and resources of the two companies, to develop a broad portfolio of hemophilia products. As announced in late August 2011, Ipsen and Inspiration extended their agreement to create a hemophilia business unit structure that will act as the exclusive sales organization for all hemophilia products commercialized under the Inspiration brand in Europe. For further information on Inspiration, please visit http://www.inspirationbio.com.Contacts:Media

CompanyKate Lewis

Gordon H. BusenbarkDan Quinn

Senior Vice President, Chief Financial OfficerFeins
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Using magnetic toys as inspiration, researchers tease out structures of self-assembled clusters
3. Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B
4. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
8. Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
9. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
10. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
11. Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Adult stem cells that ... biological, but not magical. However, many current ... them as if they were magical. , Many ... that constitute “stem cell tourism,” are evaluating heterologous ... developing new regenerative medicine therapies. In reality, these ...
(Date:7/22/2014)... Piscataway, NJ (PR Web) July 21, 2014 (PRWEB) ... Jersey Center for Biomaterials, at Rutgers University. ... exchange information and ideas across the full spectrum ... focusing on selected research and development topics that ... application. Activities have been programmed to:, ...
(Date:7/22/2014)... 22, 2014 Even within a phylum so full of ... among other arthropods for its cruelty -- at least to ... the fly is a most predatory sort of parasite. It ... a smear of larvae, and leaves its wicked brood to ... , None of this would be possible without the fly,s ...
(Date:7/22/2014)... solution of rod-shaped metal nanoparticles in water with ultrasound ... drill bits. Why? No one yet knows exactly. But ... (NIST) have clocked their speedand it,s fast. At up ... times faster than any nanoscale object submerged in liquid ... has opened up the possibility that they could be ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... All Conditions to the Tender Offer Have Been Satisfied, ... and,Investments Ltd. (TASE: CII) announced today that all of ... to purchase,up to 2,338,686 ordinary shares of Fundtech Ltd. ... to the seller in cash, less any required,withholding taxes ...
... and employees in Massachusetts, encompassing over 250,000 square feet for ... ... CANTON, Mass., April 3, 2008 Joined by local officials,and Organogenesis, ... company, which was once,planning to move its operations outside of the ...
... DNDN ) today announced that it has entered into ... million shares of its,common stock and warrants to purchase ... gross proceeds of approximately $47 million, before,deducting placement agent ... The investor has agreed to purchase the,shares of common ...
Cached Biology Technology:Clal Industries Commences Additional Offer Period for Fundtech Tender Offer 2Clal Industries Commences Additional Offer Period for Fundtech Tender Offer 3Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 2Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 3Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 4Dendreon Announces $47 Million Registered Direct Offering 2Dendreon Announces $47 Million Registered Direct Offering 3
(Date:7/23/2014)... membrane degradation and blood-brain barrier damage appear ... brain functioning. Matrix metalloproteinase-9 is able to ... membrane around cerebral blood vessels and to ... Hou and colleagues from the First Affiliated ... University, China induced cerebral infarction in stroke-prone ...
(Date:7/23/2014)... German . ... of Molecular Cell Biology and Genetics in Dresden ... images of cardiac dynamics in zebrafish. The novel ... (SPIM) and clever image processing to reconstruct multi-view ... have developed a method of generating high-resolution static ...
(Date:7/22/2014)... professor with an expertise in big data and bioinformatics ... more than $600,000 to develop an interactive database of ... associate professor, will lead the project with professor Chris ... Engineering department. Scientists are compiling and studying data related ... involved in fruit fly development are commonly found in ...
Breaking Biology News(10 mins):Unbreak my heart 2UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... to improving bone health in postmenopausal women and people ... has found a simple, proactive solution to help prevent fractures ... have tested numerous fruits, including figs, dates, strawberries and raisins, ... effect on bone density that dried plums, or prunes, have," ...
... University allows amputees to walk without the leg-dragging gait ... the latest advances in computer, sensor, electric motor and ... the first prosthetic with powered knee and ankle joints ... that monitor its user,s motion. It has microprocessors programmed ...
... INDIANAPOLIS -- An Indiana University scientist studying human bone ... U.S. Department of Defense to study a chemical compound ... healing. Hiroki Yokota, professor of biomedical engineering at ... anatomy and cell biology at the IU School of ...
Cached Biology News:No bones about it: Eating dried plums helps prevent fractures and osteoporosis 2New 'bionic' leg gives amputees a natural gait 2New compound may accelerate bone healing, prevent osteoporosis 2New compound may accelerate bone healing, prevent osteoporosis 3
Competitors to lower non-specific signal...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Biology Products: